31 – 40 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- 4
- next »
- 2009
-
Mark
Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports
2009) Symposium on Expanding the Boundaries of Clinical Practice - Building an Experience with Targeted Therapies 20. p.25-31(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2007
-
Mark
Familial blood vessel tumors and subsequent cancers
(
- Contribution to journal › Article
- 2005
-
Mark
2004 consensus statements on the management of ovarian cancer : final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16 Suppl 8. p.7-12(
- Contribution to journal › Article
-
Mark
Clinical trials in ovarian carcinoma : study methodology
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.20-29(
- Contribution to journal › Article
-
Mark
3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38(
- Contribution to journal › Article
- 2000
-
Mark
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(3). p.8-281(
- Contribution to journal › Article
-
Mark
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550(
- Contribution to journal › Article
- 1998
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
-
Mark
Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients. Scandinavian Breast Group, Study SBG 9401
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(4). p.403-411(
- Contribution to journal › Article
- 1993
-
Mark
Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin
1993) In Annals of oncology : official journal of the European Society for Medical Oncology 4(Suppl 3). p.31-34(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- 4
- next »